At least, that is essentially what he is. Alan Krensky, MD has been named the first NIH Deputy Director for the Office of Portfolio Analysis and Strategic Initiatives (OPASI). In addition to Roadmap initiatives, he’ll monitor scientific advances and needs to identify funding priorities that do not neatly fall under the mission of one or two ICs. Topic areas such as inflammatory response … especially relevant given his current role at Stanford as Chief of the Division of Immunology and Transplantation Biology, Associate Chair for Research in the Department of Pediatrics, and Associate Dean for Children’s Health. His starts his new position at the NIH on July 8, 2007.
NIH Director of Trans-Institute Research